Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00223821 · ClinicalTrials.gov registry record · NA
Enhancing Conservative Treatment for Urge Incontinence
A NA study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 166
- Enrollment target
NCT00223821 is a NA study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 166 participants.
The verdict
NCT00223821, a NA study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 166 participants
- Enrollment target
Study Summary
The primary objective of this project is to evaluate whether enhancing drug therapy with components of behavioral training, including pelvic floor muscle rehabilitation, results in better outcomes than drug therapy alone for urge incontinence in community-dwelling women.
Interventions
- DRUG Oxybutynin chloride, extended-release, individually-titrated
- BEHAVIORAL Behavior Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2003-09 |
| Est. Completion | 2009-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00223821
The ClinicalTrials.gov registry entry for NCT00223821 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 166 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Oxybutynin chloride, extended-release, individually-titrated is the first listed.
NCT00223821 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00223821 about?
NCT00223821 is a clinical study titled "Enhancing Conservative Treatment for Urge Incontinence". The primary objective of this project is to evaluate whether enhancing drug therapy with components of behavioral training, including pelvic floor muscle rehabilitation, results in better outcomes than drug therapy alone for urge incontinence in community-dwelling women.
What is the current status of trial NCT00223821?
This trial is currently completed. It is a NA study. The enrollment target is 166 participants. The study started on 2003-09. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00223821?
The interventions under investigation include: Oxybutynin chloride, extended-release, individually-titrated (DRUG), Behavior Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT00223821?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.